Nie R, Wu Z, Ni J, Zeng F, Yu W, Zhang Y, et al. Porphyromonas gingivalis Infection Induces Amyloid-β Accumulation in Monocytes/Macrophages. J Alzheimers Dis. 2019;72:479-494 pubmed publisher

Wang X, Wang L, Yu X, Li Y, Liu Z, Zou Y, et al. Glutaminyl cyclase inhibitor exhibits anti-inflammatory effects in both AD and LPS-induced inflammatory model mice. Int Immunopharmacol. 2019;75:105770 pubmed publisher

Murray C, Gami Patel P, Gkanatsiou E, Brinkmalm G, Portelius E, Wirths O, et al. The presubiculum is preserved from neurodegenerative changes in Alzheimer's disease. Acta Neuropathol Commun. 2018;6:62 pubmed publisher

Schmidt F, Boltze J, Jäger C, Hofmann S, Willems N, Seeger J, et al. Detection and Quantification of β-Amyloid, Pyroglutamyl Aβ, and Tau in Aged Canines. J Neuropathol Exp Neurol. 2015;74:912-23 pubmed publisher

Hartlage Rübsamen M, Waniek A, Meissner J, Morawski M, Schilling S, Jäger C, et al. Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease. Acta Neuropathol. 2015;129:565-83 pubmed publisher

Waniek A, Hartlage Rübsamen M, Höfling C, Kehlen A, Schilling S, Demuth H, et al. Identification of thyrotropin-releasing hormone as hippocampal glutaminyl cyclase substrate in neurons and reactive astrocytes. Biochim Biophys Acta. 2015;1852:146-55 pubmed publisher

Sieczkowski E, Milenkovic I, Venkataramani V, Giera R, Ströbel T, Höftberger R, et al. I716F AβPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-β and α-synucleinopathy with Lewy bodies. J Alzheimers Dis. 2015;44:103-14 pubmed publisher

Bayer T, Wirths O. Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease. Acta Neuropathol. 2014;127:787-801 pubmed publisher

Kalimo H, Lalowski M, Bogdanovic N, Philipson O, Bird T, Nochlin D, et al. The Arctic A?PP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated A?. Acta Neuropathol Commun. 2013;1:60 pubmed publisher

Morawski M, Schilling S, Kreuzberger M, Waniek A, Jäger C, Koch B, et al. Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-? load and cognitive decline in Alzheimer's disease. J Alzheimers Dis. 2014;39:385-400 pubmed publisher

Becker A, Kohlmann S, Alexandru A, Jagla W, Canneva F, B uscher C, et al. Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration. BMC Neurosci. 2013;14:108 pubmed publisher

Wirths O, Hillmann A, Pradier L, Hartig W, Bayer T. Oligomeric pyroglutamate amyloid-? is present in microglia and a subfraction of vessels in patients with Alzheimer's disease: implications for immunotherapy. J Alzheimers Dis. 2013;35:741-9 pubmed publisher

Wittnam J, Portelius E, Zetterberg H, Gustavsson M, Schilling S, Koch B, et al. Pyroglutamate amyloid ? (A?) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease. J Biol Chem. 2012;287:8154-62 pubmed publisher

Morawski M, Brückner G, Jäger C, Seeger G, Matthews R, Arendt T. Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology. Brain Pathol. 2012;22:547-61 pubmed publisher

Hartlage Rübsamen M, Morawski M, Waniek A, Jäger C, Zeitschel U, Koch B, et al. Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-A? deposits in hippocampus via distinct cellular mechanisms. Acta Neuropathol. 2011;121:705-19 pubmed publisher

Jawhar S, Trawicka A, Jenneckens C, Bayer T, Wirths O. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A? aggregation in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging. 2012;33:196.e29-40 pubmed publisher

Morawski M, Hartlage Rübsamen M, Jäger C, Waniek A, Schilling S, Schwab C, et al. Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer's disease. Acta Neuropathol. 2010;120:195-207 pubmed publisher

Hartig W, Goldhammer S, Bauer U, Wegner F, Wirths O, Bayer T, et al. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice. J Chem Neuroanat. 2010;40:82-92 pubmed publisher

Wirths O, Bethge T, Marcello A, Harmeier A, Jawhar S, Lucassen P, et al. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases. J Neural Transm (Vienna). 2010;117:85-96 pubmed publisher

Wirths O, Breyhan H, Cynis H, Schilling S, Demuth H, Bayer T. Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model. Acta Neuropathol. 2009;118:487-96 pubmed publisher